Cancer Incidence & Mortality in Maine 1995-1996 by Maine Department of Human Services et al.
Maine State Library
Digital Maine
Center for Disease Control Documents Health & Human Services
1-1-2002
Cancer Incidence & Mortality in Maine
1995-1996
Maine Department of Human Services
Maine Center for Disease Control and Prevention
Maine Cancer Registry
Follow this and additional works at: https://digitalmaine.com/mecdc_docs
This Text is brought to you for free and open access by the Health & Human Services at Digital Maine. It has been accepted for inclusion in Center for
Disease Control Documents by an authorized administrator of Digital Maine. For more information, please contact statedocs@maine.gov.
Recommended Citation
Maine Department of Human Services, Maine Center for Disease Control and Prevention, and Maine Cancer Registry, "Cancer
Incidence & Mortality in Maine 1995-1996" (2002). Center for Disease Control Documents. 126.
https://digitalmaine.com/mecdc_docs/126
Cancer 
Incidence & Mortality 
in Maine
1995-1996
Maine 
Cancer Registry
1
9
9
5
-
1
9
9
6
Cancer Incidence and Mortality In Maine, 1995-1996
Prepared by:
Margaret Parsons, MD, MPH
Medical Director
Maine Cancer Registry
Judith Graber, MS
Former Epidemiologist
Maine Cancer Registry
Castine Verrill, MS
Epidemiologist
Maine Cancer Registry
Special thanks to the following individuals and organizations:
The Maine Cancer Registry Staff
Office of Data, Research, and Vital Statistics
Department of Human Services
Maine hospital registrars:
We would also like to extend our thanks to the Maine hospitals for reporting cancer cases to
the Maine Cancer Registry. Without their support this report would not be possible.
Burgess Advertising & Associates, Inc. for donations of services in producing this report.
Additional information and copies may be obtained from:
The Maine Cancer Registry
11 State House Station
Key Bank Plaza, 4th Floor
Augusta, ME 04333-0011
Tel: (207) 287-5272
Fax: (207) 287-4631
1Table of Contents
Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
Introduction: What is the Maine Cancer Registry?  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Common Cancer Sites
All Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Lung Cancer  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
Female Breast Cancer  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14
Prostate Cancer  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
Colorectal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22
Bladder Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .26
Oral and Throat Cancer  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30
Cervical Cancer  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34
Melanoma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .38
Data Tables  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42
Technical Notes  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45
Glossary of Terms  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48
ICD-O Codes  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50
References  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53
Informational Resources  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
2Executive Summary
Cancer is a widespread disease that affects people around the world. A national program
called "Healthy People 2010" was developed to establish measurable goals to help increase
the quality and number of healthy years of life. One of the key goals of this program is to
reduce the number of new cancer cases as well as the illness, disability, and death caused
by cancer. In Maine, the Comprehensive Cancer Control Consortium was developed to
address the burden of cancer in our state. A plan has been developed to improve preven-
tion, early detection, treatment, rehabilitation, survivorship, palliation, and hospice care for
the people of Maine.
In our lifetime, each of us will undoubtedly be touched by cancer in one way or another.
The American Cancer Society reports that one out of every two men and one out of every
three women will be diagnosed with some form of cancer in their lifetimes. In Maine an
estimated 6,900 new cases will be diagnosed in the year 2001. Cancer is the second lead-
ing cause of death in the United States and in Maine. The American Cancer Society esti-
mates that 3,000 Maine residents will die from cancer in the year 2001. 
Cancer is not a single disease. There are over 100 different types of cancer, each with its
own behavior, treatment, and survival rate. Four types of cancer account for over 50% of
all cases diagnosed in Maine: lung (16.6%), female breast (14.7%), prostate (12.8%), and
colorectal (12.0%). Bladder cancer accounts for an additional 5.5% of the cases. During
the 1995 to 1996 time period, Maine’s cancer mortality was the fifth highest in the nation.
Maine had the second highest bladder cancer mortality rate, the fifth highest colorectal
cancer rate, and the eighth highest lung cancer rate. Maine women ranked 18th highest in
breast cancer and Maine men ranked 20th in prostate cancer. 
There are various causes of cancer. The 1996 Harvard Report on Cancer Prevention con-
cluded that 65% of all cancer deaths could be attributed to three modifiable lifestyle fac-
tors: tobacco use, adult diet and obesity, and a sedentary lifestyle. Heredity and environ-
mental factors, such as pollution, viruses, occupational exposures and ultraviolet radiation,
also contribute to the development of cancer. Because cancer can take up to 30 years to
develop, it is difficult to pinpoint a particular exposure that might have contributed to a
given cancer. While hereditary factors are not modifiable, people can reduce their risk of
developing cancer by exercising, eating a healthy diet, and not smoking.
The goal of this annual report is to provide educational and statistical information on can-
cer in the state of Maine. The report represents data collected from 38 hospitals, physician
offices, and pathology labs in Maine. Additional data is contributed by other states that
care for Maine residents with cancer. The report explains the purpose of the Maine Cancer
Registry and provides incidence and mortality data for all cancers combined, for the five
most common cancer sites (lung, breast, prostate, colorectal, and bladder), and for three
sites where preventive measures can also be implemented (cervical, oral, and melanoma).
Risk factors and methods of prevention are included for each cancer site. Detailed data
tables by county and more specific cancer sites are also included. 
Note: Due to changes in our case-finding methods, which began in 1995, we have not
included time trends for Maine. Time trends will be resumed in future reports.
What is the Maine Cancer Registry?
The Maine Cancer Registry (MCR) is a statewide population-based cancer surveillance system. 
The MCR collects information about all newly diagnosed and treated cancers in Maine residents
(except basal and squamous cell carcinoma of the skin). This information is used to better 
understand cancer and improve cancer prevention, treatment and control.  
Where does the MCR’s authority and funding come from?
State law created the MCR in 1983 (MRSA 22 1401-1404).
Federal law provided funds for the MCR to expand in 1994, under the National Program of
Cancer Registries, a program of the Centers for Disease Control and Prevention (USC Title 42-
280e). Today the CDC provides three dollars for the MCR for every dollar from the state.
Where do cancer case reports come from?
All hospitals, health care facilities, physicians, and other providers who diagnose or treat cancer
patients are required by law to report new cases to the MCR.
The MCR also actively finds new cancer cases in other databases at independent labs, state
death files and other state registries. 
What kind of information is reported?
■ About the person: age, sex, race, residence, occupation
■ About the cancer: which body part (site), how far it has spread (stage)
■ Treatment: surgery, radiation, chemotherapy
How is the information kept confidential?
The MCR follows strict requirements of federal and state law to keep all personal informa-
tion confidential. This means that any information that could identify a person is kept in locked
files or secure computer accounts. Very specific guidelines are followed when data are released. 
What does the MCR do with reported cases?
The MCR spends a lot of time making sure that the information is complete and accurate. For
example, because more than one source often reports the same case, MCR staff must make sure
that each case is in the database only once. MCR staff are specially trained to do this quality
assurance work and keep these skills up to date with continuous education.
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How are MCR cancer data used?
MCR data are currently used in several forms, including: 
■ the annual report, which is often used to answer general questions by the public; 
■ special reports which are generated in response to requests for aggregated data; 
■ identifiable data sets for researchers in the field of cancer; 
■ investigating local concerns about cancer rates; and 
■ data submissions for larger collaborative efforts. 
Examples of these current uses are listed below:
Data Use Types of Users
Annual Report • Public Health Organizations 
(private and public)
• Other State Agencies
Summary data reports • Comprehensive Cancer 
Planning Initiatives
Identifiable data for research • Researchers and Planners
Local concerns about rates • State Agencies  • Towns  • Industries
Data submissions • North American Association of Central Cancer Registries 
• National Program of Cancer Registries
• Central Brain Tumor Registry of the United States
• Hospitals • Students
• Universities • State Agencies
• Legislators • Health Insurance 
• Hospitals Companies
• Universities • Private Citizens
Facts About Cancer in the U.S.
In 1996 an estimated 1,359,150 people in the U.S.
were diagnosed with cancer and 554,740 people
died from some form of this disease. Cancer varies
by climate and region. In the U.S. cancer is 
diagnosed more often in the Northeast and areas
of the South. Cancer is more common in men
than in women. One in every two men and one in
every three women will be diagnosed with cancer
in his or her lifetime. Cancer is more common with
increasing age.
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The key to 
preventing death 
from cancer 
is to find it early 
when it 
can be cured.
All Cancers
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Risk Factors for Cancer
The Harvard Report on Cancer Prevention in 1996 researched the risk factors for cancer.
The estimated percent of total cancer deaths attributed to established causes of cancer were:
Risk Factor Percentage
Tobacco 30%
Adult diet/obesity 30%
Sedentary lifestyle 5%
Occupational factors 5%
Family history of cancer 5%
Viruses/biological agents 5%
Perinatal factors/growth 5%
Reproductive factors 3%
Alcohol 3%
Socioeconomic status 3%
Environmental pollution 2%
Ionizing/UV radiation 2%
Other 2%
Prevention
The most successful way to prevent cancer is to limit the number of modifiable risk 
factors by following these guidelines:
■ Do not smoke 
■ Eat a diet high in fresh fruits and vegetables and low in fats
■ Get some exercise every day
■ Limit alcohol intake
Early Detection
Recommended screening tests are listed here and discussed in more detail in the following
chapters:
■ Mammogram
■ Pap Smear 
■ Colorectal Exam
■ Mouth and Throat Exam
■ Skin Cancer Screening
■ Prostate Screening
Facts about Cancer in Maine
■ In 1995 and 1996, cancer was the second leading cause of death after 
heart disease and accounted for 25% of all deaths in Maine. 
■ Cancer was the number one cause of potential years of life lost, account-
ing for 1,543 years per 100,000 people in Maine. Heart disease only
accounted for 950 years of potential life lost. This measure indicates that 
cancer deaths occur in people at a much younger age than heart disease.
Risk Factors in Maine
The 2000 Behavioral Risk Factor Surveillance System (BRFSS) shows that:
■ Over 23% of Maine adults smoke cigarettes.
■ Over 75% of Maine residents do not eat the recommended five or more 
servings of fruits and vegetables a day.
■ Over 27% of Maine residents indicate that they have not participated in 
any physical activity in the past month. This may contribute to obesity.
Maine: 227.9 per 100,000
U.S.: 209.5 per 100,000
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Maine: 145.8 per 100,000
U.S.: 135.9 per 100,000
Note:  Mortality rate/100,000 age-adjusted to 1970 U.S. population
Source:  Atlas of Cancer Mortality in the U.S. 
219.09 to 233.52 (11)
214.67 to 219.09 (10)
201.41 to 214.67 (11)
191.46 to 201.41 (10)
150.13 to 191.46 (9)
141.83 to 151.14 (11)
136.81 to 141.83 (10)
127.60 to 136.81 (11)
122.71 to 127.60 (10)
104.29 to 122.71 (9)
Age-Adjusted Mortality Rates for All Cancers, White Females, 1970-1994
Age-Adjusted Mortality Rates for All Cancers, White Males, 1970-1994
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Early Detection in Maine
The 2000 BRFSS shows the following patterns of early detection
in Maine:
■ Breast Cancer: Approximately 90% of the women in Maine,
over age 40, have ever had a mammogram. However, only
75% of these women have had the mammogram within the
screening guideline of one year.  
■ Cervical Cancer: Ninety-four percent of Maine women have
ever had a Pap Smear. Of these women, 73% have had the Pap
Smear within the recommended timeframe of one year.  
■ Colon Cancer: The 1999 BRFSS shows that only 36% of men
and women in Maine, over age 50, have had a fecal occult
blood test (FOBT). Only 34% of Maine men and women, over
age 50, have had either a sigmoidoscopy or colonoscopy. 
Burden of Cancer in Maine
■ In 1995 and 1996 an average of 3,098 men and 3,020 women
were diagnosed with some form of cancer.
■ 1,532 men and 1,435 women died of cancer each year.  
■ Over 68% of new cancers in Maine are diagnosed in people
over 60 years old. 
Within Maine, there is a 
lot of random variation
between the county 
rates. Counties whose
rates for all cancers 
combined are 
significantly lower 
than the rate in Maine
include Cumberland 
and Sagadahoc. 
Counties with a 
significantly higher rate
of all cancers combined
include Hancock, 
Penobscot, and 
Washington Counties. 
(See Data Tables, page 42, for
95% confidence intervals.)
Maine = 398.8
National (SEER1 Whites) =
391.9
1 Surveillance, Epidemiolgy, 
and End Results
Maine Age-Adjusted
Cancer Incidence Rates
by County
All Sites 1995-1996
Cancer was 
the number one
cause of potential 
years of life lost, 
accounting for
1,543 years 
per 100,000 
people in Maine. 
Prostate cancer is the
most commonly 
diagnosed cancer in
Maine males, followed
by lung, colorectal, and
bladder cancer. These
four types of cancer
account for almost 
two-thirds (63.4%) of
all newly diagnosed
cancers in males for
1995 and 1996.
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Rate per 100,000
Prostate gland
Lung
Colon and Rectum
Bladder
Non-Hodgkin’s Lymphoma
Oral Cavity and Throat
Melanomas
Leukemias
Pancreas
Stomach
Larynx
Brain and CNS
Esophagus
Multiple myeloma
Testis
Pleura
Tongue
Liver
Tonsil
Soft tissue
Gum and mouth
Male Breast
Bones and joints
Breast cancer is the
most commonly 
diagnosed cancer in
Maine females, 
followed by lung, 
colorectal, and uterine 
cancer. These four types
of cancer account for
more than two-thirds
(69.2%) of all cancers
diagnosed in females
for 1995 and 1996.
0 20 40 60 80 100 120
Rate per 100,000
Female Breast
Lung
Colon and Rectum
Uterus
Non-Hodgkin’s Lymphoma
Ovary
Melanomas
Cervix uteri
Bladder
Pancreas
Leukemias
Oral Cavity and Throat
Brain and CNS
Multiple myeloma
Stomach
Larynx
Soft tissue
Gum and mouth
Tonsil
Esophagus
Bones and joints
Liver
Tongue
Pleura
Distribution of Age-Adjusted Incidence Rates in Maine by Site
Males, 1995-1996
Distribution of Age-Adjusted Incidence Rates in Maine by Site
Females, 1995-1996
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Cancer is more common
as people get older.  
For each age group
over 60, the cancer
rates are much higher
for men than for
women.
Maine Age-Specific Incidence Rates
All Cancers, 1995-1996
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The age-adjusted 
incidence rates for all
types of cancer 
combined in Maine men
and women were not 
statistically different
from the U.S. 
There were more deaths
due to all cancers in
Maine men and women
than in the U.S. 
This difference was 
statistically significant.
The difference may be
due to a number of 
factors, including a lack
of access to cancer
screenings and delayed
diagnosis or access to
appropriate treatment.
Age-Adjusted Incidence Rates by Sex, Maine and U.S.
All Cancers, 1995-1996
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
All Cancers, 1995-1996
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Note: Rates are age-adjusted to the 1970 U.S. standard population
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Lung Cancer in the U.S.
Lung cancer is the third most common cancer,
after breast and prostate cancer. It accounts for
13% of all new cancer cases. Because of its low
survival rate, lung cancer is the leading cause of
cancer deaths, accounting for 28% of the total. 
In the year 1996, an estimated 177,000 new cases
were diagnosed in the U.S. and 158,700 people
died from lung cancer. In the late 1980’s, lung 
cancer deaths for U.S. men stopped rising and
have been slowly falling since the early 1990’s.
However, for women, lung cancer deaths 
continued to rise in the 1990’s.
Lung Cancer
Because of its 
low survival rate, 
lung cancer is 
the leading cause 
of cancer deaths,
accounting for 
28% of the total.
The most effective 
prevention for 
lung cancer 
is to never smoke.
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Risk Factors for Lung Cancer
■ Smoking is currently estimated to cause 85-90% of all lung cancer cases. The more 
you smoke the more likely you are to get lung cancer.
■ The risk of dying from lung cancer is 22 times higher among male smokers and 
12 times higher among female smokers than among people who have never smoked.
■ Cigar and pipe smoking increase the risk of lung cancer.
■ Breathing second-hand smoke also contributes to lung cancer risk for non-smokers.
■ Two well-know causes of work-related lung cancer are radon and asbestos.  
■ People may also be exposed to enough radon at home to increase their chance of 
developing lung cancer, especially if they smoke. 
■ People with low intakes of fruits and vegetables have a higher risk of developing 
lung cancer.
Prevention of Lung Cancer
■ The most effective prevention for lung cancer is to never smoke.
■ Even if you have already smoked, quitting now can make a difference. Ten years after
quitting, cigarette smokers cut their chances of getting lung cancer in half.
■ Homes should be tested for radon.
Early Detection of Lung Cancer
■ There are no good screening tests to detect lung cancer early.
■ Only 15% of lung cancers are found at the earliest stage, and even for these people, 
only half will be alive five years later.
■ Cases detected late (when disease has spread to another part of the body) have only a
15% chance of living five more years.
■ The best way to reduce the chance of dying of lung cancer is to not smoke tobacco.
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The age-adjusted 
mortality rate for lung
cancer was statistically
higher (more deaths)
for both men and
women in Maine 
compared to the U.S.
The age-adjusted 
incidence rates for 
lung cancer in both 
men and women were 
statistically higher
(more cases) in Maine
than the U.S. While
there are many factors
that may contribute to
this difference, smoking
is a major cause of 
lung cancer in Maine.
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Age-Adjusted Incidence Rates by Sex, Maine and U.S.
Lung Cancer, 1995-1996
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
Lung Cancer, 1995-1996
Radon in Maine Homes
■ Approximately 1/3 of Maine homes have radon concentrations above the U.S.
EPA’s action level of 4 picocuries per liter of air.
■ All Maine homes should be tested for radon.
■ For additional information about testing for radon in your home call the
Maine Bureau of Health, Radiation Control Program at  (800) 232-0842.  
Burden of Lung Cancer in Maine
■ In 1995 and 1996, an average of 577 men and 441 women each year were
diagnosed with lung cancer.
■ During the same time period, an average of 527 men and 374 women each
year died of lung cancer.  
■ Over 80% of the lung cancer cases diagnosed in Maine are in men and women
over 60 years old. 
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Within Maine, only 
Washington County has 
a statistically higher rate
of lung cancer incidence
than the rest of the state. 
(See Data Tables, page 42, for
95% confidence intervals.)
Maine = 66.3
National (SEER1 Whites) =
55.3
1 Surveillance, Epidemiolgy, 
and End Results
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Maine Age-Adjusted
Lung Cancer
Incidence Rates 
by County
1995-1996
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Lung cancer is much
more common as 
people get older. 
Within each age group,
the rates are much
higher for men than 
for women.
Maine Age-Specific Incidence Rates
Lung Cancer, 1995-1996
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Breast Cancer in the U.S.
Breast cancer rates in the United States are among
the highest in the world. Breast cancer is the most 
common cancer among women in the United
States, accounting for 30% of all cancer in
women. It is the second leading cause of cancer-
related deaths (after lung cancer) among U.S.
women. In 1996 an estimated 184,300 women in
the U.S. got breast cancer and 44,300 died from
it. From 1973 to 1991, invasive breast cancer in
the United States increased 25.8 percent in 
White women. Although early detection (using
mammograms) accounts for some of this increase,
other factors play a role. From 1989-96, 86.4% 
of White females and 71.4% of African American
females survived for at least five years after being
diagnosed with breast cancer.
Breast Cancer
Most women with 
breast cancer 
do not have any 
known risk factors
besides older age.  
Risk Factors for Breast Cancer
■ One of the strongest risk factors is older age.
■ Some genetic factors are believed to play a role in a small number of breast cancers,
such as having a close female relative (mother, sister, daughter) with breast cancer or
inheritance of the breast cancer gene BRCA1 or BRCA2. 
■ Other factors related to a woman’s medical history may increase risk, including: 
• First full-term pregnancy after age 32, or never having borne a child.
• Being overweight (mainly after menopause).
• A history of breast, ovarian, or endometrial cancer.
• Atypical hyperplasia or a high degree of dense breast tissue.
• Long term use of high doses of estrogen (such as oral contraceptives or hormone 
replacement therapy). 
■ Some environmental exposures may contribute to breast cancer risk, such as high doses
of radiation in infancy or from puberty through the childbearing years or more than two
drinks of alcohol a day.
Prevention of Breast Cancer
Most women with breast cancer do not have any known risk factors besides older age.
However, some studies suggest that there are fewer cases of breast cancer among
groups of women who do the following: 
■ Maintain a healthy weight
■ Avoid prolonged use of estrogen
■ Do not drink excess amounts of alcohol 
Early Detection of Breast Cancer
Why is early detection important?  
■ Cases detected early (local disease) have about a 96% chance of living for at least five
more years.
■ Cases detected late (disease that has spread to another part of the body) have only a
21% chance of living for five more years.
How to Improve your Chances of Detecting 
Breast Cancer Early
■ Have a health care provider examine your breasts every year. 
■ Learn from your provider how to examine your own breasts and do it every month.
■ Get your first screening mammogram when you turn 40 and earlier if your provider advises
because of other risks factors, such as:
• a close female relative with breast cancer
• a biopsy with “atypical hyperplasia”
• carrying the genes BRCA1 or BRCA2
■ Get a screening mammogram every 1-2 years between 40 and 49 years of age and every
year after age 50.
15
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Burden of Breast Cancer in Maine
■ In 1995 and 1996 an average of 889 women were diagnosed with
breast cancer each year.
■ An average of 218 women died of breast cancer each year.  
■ In Maine, 60% of breast cancer cases are diagnosed after age 60,
reflecting a higher rate of breast cancer after menopause. 
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The age-adjusted 
incidence rate of breast
cancer in Maine is not
statistically different
from the U.S. 
The age-adjusted 
mortality rate of breast
cancer in Maine is not
statistically different
from the U.S. 
Age-Adjusted Incidence Rates, Maine and U.S.
Female Breast Cancer, 1995-1996
Age-Adjusted Mortality Rates, Maine and U.S.
Female Breast Cancer, 1995-1996
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As with most types of
cancer, breast cancer is
more common as
women get older.  
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Within Maine, no 
counties are significantly
higher or lower than the
rest of the state. 
(See Data Tables, page 42, for
95% confidence intervals.)
Maine = 108.2
National (SEER1 Whites) =
114.3
1 Surveillance, Epidemiolgy, 
and End Results
Maine Age-Adjusted
Breast Cancer
Incidence Rates 
by County
1995-1996
Maine Age-Specific Incidence Rates 
Female Breast Cancer, 1995-1996
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Prostate Cancer in the U.S.
Prostate cancer is the most common cancer
among U.S. men, accounting for 29% of all cancer
cases in males. In 1996 an estimated 317,100 men
were diagnosed with prostate cancer and 41,400
died from this disease. Prostate cancer is primarily
a disease of older men. The rate doubles every ten
years after the age of 40. In the 1970’s and 1980’s
prostate cancer incidence rose steadily, but since
1992 has decreased. Some of the increase in cases
may have been due to finding more cases at an
earlier stage, through screening and routine 
surgeries. Since the early 1990’s the mortality 
rates have also decreased. However, deaths from
prostate cancer in African American men remain
over twice as high as White men.
Prostate Cancer
Older age is 
the biggest risk factor 
for prostate cancer.
Men aged 50 years 
or older with no 
risk factors should 
talk with their 
health care providers
about being screened
for prostate cancer
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Risk Factors for Prostate Cancer
■ As with many cancers, older age is the biggest risk factor for prostate cancer.
■ Prostate enlargement (benign prostatic hypertrophy) may increase the risk for some men.
■ A history of prostate cancer in a close family member may also increase an 
individual’s risk.
■ Recent steady increases in prostate cancer incidence and mortality suggest that some
environmental factors, such as dietary animal fat, may play a role, but these are not 
definite. 
Prevention of Prostate Cancer
It is not yet understood how best to prevent prostate cancer.  Early detection may be the
best strategy for reducing the chances of dying from this disease.  
Early Detection of Prostate Cancer
Why is early detection important?  
■ Cases detected early (local disease) have about a 100% chance of living for at least 
five more years.
■ Cases detected late (disease that has spread to another part of the body) have only 
a 34% chance of living for five more years.
How to Improve your Chances of Detecting
Prostate Cancer Early
■ Men aged 50 years or older with no risk factors should talk with their health care
providers about being screened for prostate cancer with a digital rectal exam and
blood test (PSA).
■ Men with risk factors, such as a family history of prostate cancer, may want to talk
with their providers about being screened earlier.  
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Burden of Prostate Cancer in Maine
■ In 1995 and 1996 an average of 781 cases of prostate cancer were
diagnosed each year.
■ On average, 188 men died from prostate cancer each year during this
time period.  
■ Over 88% of prostate cancer cases occur in men over 60 years old. 
Age-Adjusted Incidence Rates, Maine and U.S.
Prostate Cancer, 1995-1996
Age-Adjusted Mortality Rates, Maine and U.S.
Prostate Cancer, 1995-1996
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The age-adjusted 
incidence rate for
prostate cancer in
Maine is statistically
lower (fewer cases)
than the U.S. rate.  
The lower rate may
reflect underreporting
of new cases from
physician’s offices,
where more prostate
cancers are now being
diagnosed.
The age-adjusted 
mortality rate for
prostate cancer is 
statistically higher
(more deaths) in Maine
than in the U.S.
Within Maine, 
the incidence rate is 
significantly lower in
both Cumberland and
Sagadahoc Counties 
than the rest of the
state. Aroostook County
has a significantly higher
rate of prostate cancer. 
(See Data Tables, page 42, for
95% confidence intervals.)
Maine = 114.7
National (SEER1 Whites) =
130.0
1 Surveillance, Epidemiolgy, 
and End Results
Maine Age-Adjusted
Prostate Cancer
Incidence Rates by
County
1995-1996
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As with most types of
cancer, prostate cancer
is more common as 
people age.  In Maine,
the rate of new cases
rises dramatically after
age 60. 
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Colorectal Cancer in the U.S.
Colorectal cancer is the third most common cancer
among U.S. men and women, following prostate
and lung cancer in men and breast and lung cancer
in women. Colorectal cancer is the second leading
cause of cancer deaths in the U.S. In 1996 an 
estimated 133,500 people in the U.S. were 
diagnosed with colorectal cancer and 54,900 died
from this disease. Until the mid 1980’s, cancer was 
diagnosed as often among African Americans as
Whites; however, in 1986 White rates began to
decline while African American rates did not.
Similarly, the number of deaths from colorectal 
cancer began to slowly decline among Whites in the
early 1980’s while it remained steady among African
Americans. Industrialized countries in North America
and Western Europe tend to have much higher
rates of colorectal cancer cases and deaths than the
less industrialized countries in Africa and Asia. 
Colorectal Cancer
Cases detected early 
(local disease) 
have about a 90%
chance of living 
for at least 
five more years.
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Risk Factors for Colorectal Cancer
Studies over many years have shown several factors to be associated with colorectal cancer:
■ A personal or family history of colorectal polyps or cancer 
■ Not exercising
■ Eating a lot of red meat and saturated fat
■ Not eating a lot of fruits and vegetables
Prevention of Colorectal Cancer
The most effective ways now known to reduce our chances of getting colon cancer may be 
the following:
■ Eating a diet low in red meat and animal fat 
■ Eating a diet high in fruits and vegetables (at least five servings a day)
■ Getting some exercise every day
■ Getting screened for colon polyps after age 50  
Early Detection of Colorectal Cancer
Why is early detection important?  
■ Cases detected early (local disease) have about a 90% chance of living for at least five 
more years.
■ Cases detected late (disease that has spread to another part of the body) have only an 8%
chance of living for five more years.
How to Improve your Chances of Detecting 
Colorectal Cancer Early
The average-risk person 50 years of age or older, should have one of the following tests to
screen for colorectal cancer. You and your health care provider should discuss which test is 
best for you.
■ Home stool-blood test every year
OR
■ Sigmoidoscopy every 5 years
OR
■ Home stool-blood test every year AND sigmoidoscopy every 5 years
OR
■ Colonoscopy every 10 years
OR
■ Double contrast barium enema every 5-10 years
If you have risk factors (for example you or family member has a history of colon cancer 
or polyps), you should talk to your health care provider about the best way to be
screened.
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The age-adjusted 
incidence rates for 
colorectal cancer in
both men and women
of Maine were not 
statistically different
from the U.S.
Burden of Colorectal Cancer in Maine
■ Between 1995 and 1996, 359 men and 378 women each year were
diagnosed with colorectal cancer on average.
■ On average, 143 men and 173 women died from colorectal cancer
each year. 
■ Over 80% of new cases in Maine occur in men and women over 60
years old.
Age-Adjusted Incidence Rates by Sex, Maine and U.S.
Colorectal Cancer, 1995-1996
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The age-adjusted  
mortality rates for 
colorectal cancer in
Maine were statistically
higher (more deaths)
for women but no 
different for men 
compared with the U.S.
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
Colorectal Cancer, 1995-1996
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Colorectal cancer is
more common in older
people. 
Within Maine, only
Hancock County has a 
significantly higher 
incidence rate of colorectal
cancer than the rest of 
the state. 
(See Data Tables, page 42, for
95% confidence intervals.)
Maine = 45.2
National (SEER1 Whites) =
42.4
1 Surveillance, Epidemiolgy, 
and End Results
Maine Age-Adjusted
Colorectal Cancer
Incidence Rates 
by County
1995-1996
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Bladder Cancer in the U.S.
Bladder cancer is the sixth most common cancer in
the United States. In 1996 an estimated 52,900
people in the U.S. were diagnosed with bladder
cancer and 11,700 people died from this disease.
Bladder cancer is most commonly found in white
men over age 65. White men get bladder cancer
twice as often as non-white men do. Bladder cancer
is about two to three times more common in men
than women. It is the fourth most common cancer
among men and the tenth most common among
women. From 1973 to 1991, the incidence of 
bladder cancer in the U.S. increased 10 percent, 
but has remained steady through the 1990’s in 
all gender and race groups. Internationally, the 
incidence of bladder cancer varies about 10-fold.
The disease is reported most often in Western
Europe and North America and least often in
Eastern Europe and several areas of Asia.
Bladder Cancer
In the United States, 
it is believed that 
smoking plays a role 
in almost half of 
the bladder cancers
among men 
and in a third of cases
among women. 
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Risk Factors for Bladder Cancer
■ In the United States, it is believed that smoking plays a role in almost half of the bladder
cancers among men and a third of cases among women. Cigarette smokers are 2-3 times
more likely to develop bladder cancer than nonsmokers.
■ As early as 1895, it was known that bladder cancer occurred at higher rates among 
workers exposed to dyestuffs.  Two of these chemicals, benzidine and 2-naphthylamine, 
are now known to be potent bladder carcinogens in humans and are no longer used.
■ Today 25% of bladder cancer may still be associated with some occupations, including:
rubber and leather workers, painters, drivers of trucks and other motor vehicles, aluminum
workers, machinists, chemical workers, printers, metal workers, hairdressers, and textile
workers.
■ Exposure to arsenic, a naturally occurring chemical in rocks, soil, and the water in contact
with them, can increase the risk of developing bladder cancer.
Prevention of Bladder Cancer
■ The single most important thing you can do to reduce the risk of developing bladder 
cancer is to stop smoking all kinds of tobacco (cigarettes, pipes and cigars).
■ People in higher-risk occupations should follow recommendations for protecting
themselves in the work place.
■ People using well water for drinking should have it tested for arsenic.   
Early Detection of Bladder Cancer
Why is it important?  
■ Cases detected early (local disease) have about a 94% chance of living for at least five
more years.
■ Cases detected late (disease that has spread to another part of the body) have only a 
6% chance of living for five more years.
How to Improve your Chances of Detecting 
Bladder Cancer Early
There are no screening tests for people who don’t have symptoms. If you have any of the 
following symptoms, you should see your health care provider:
■ Blood in the urine (giving it a red or pink color)
■ Having to urinate more often than usual
■ Repeated bladder infections  
Arsenic in Drinking Water
■ The EPA recommends arsenic levels below 10 micrograms per liter of
water.
■ For additional information about testing your water for arsenic, 
call the Maine Drinking Water Program at (207) 287-2070.
Burden of Bladder Cancer in Maine
■ On average 248 men and 88 women each year were diagnosed 
with bladder cancer from 1995 to 1996.
■ 48 men and 20 women each year, on average, died from bladder
cancer in Maine.  
■ Over 80% of bladder cancer cases in Maine occur in men and
women over 60 years old. 
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The age-adjusted
incidence rate for 
bladder cancer was 
statistically higher
(more cases) for Maine
men, but no different
for Maine women, 
compared with the U.S.
Age-Adjusted Incidence Rates by Sex, Maine and U.S.
Bladder Cancer, 1995-1996
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The age-adjusted 
mortality rates for 
bladder cancer in both
men and women of
Maine were not 
statistically different
from the U.S. rates.
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
Bladder Cancer, 1995-1996
8
7
6
5
4
3
2
1
0
Males Females
Maine      U.S. (SEER Whites)
Pe
r 
10
0,
00
0 
p
eo
p
le
6.9
1.7
5.7
1.7
Bladder cancer is more
common in older 
people. The incidence
of bladder cancer is
much higher in men
than women.
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Oral and Throat Cancer in the U.S.
Oral and throat cancer is the 10th most common
cancer in the U.S. In 1996 an estimated 29,490 
new cases of oral and throat cancer were diagnosed
in the U.S. Two thirds of the cases were in men, 
for whom it is the 7th most common cancer. 
In 1996, 8,260 people in the U.S. died from oral
and throat cancer. Through the 1980’s and early
1990’s the incidence and mortality rates of this 
cancer have changed very little.
Oral & Throat Cancer
In the U.S. an 
estimated 75% 
of oral and throat 
cancers are 
associated with 
tobacco or alcohol,
alone or in 
combination.
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Risk Factors for Oral and Throat Cancer
■ In the U.S. an estimated 75% of oral and throat cancers are associated with tobacco or alcohol, alone
or in combination.
■ A person who is a heavy smoker and drinker is 35 times more likely to get oral or throat cancer than
a person who does not smoke or drink.
■ Smokeless/chewed tobacco (snuff) causes high rates of this cancer in parts of the southern U.S.
■ A diet low in fresh fruits and vegetables can promote oral and throat cancer.
Prevention of Oral and Throat Cancer
■ Not smoking and reducing alcohol intake are the most effective ways for Americans to reduce their
chances of getting oral and throat cancer.
■ A smoker’s risk of getting oral and throat cancer can be cut in half within 5 years of quitting.  Ten
years after quitting, the risk may be close to a non-smoker’s.  
Early Detection of Oral and Throat Cancer
Why is it important?  
■ Cases detected early (local disease) have about an 82% chance of living for at least five more years.
■ Cases detected late (disease that has spread to another part of the body) have only a 21% chance of
living for five more years.
How to Improve your Chances of Detecting 
Oral and Throat Cancer Early
■ See your dentist regularly and ask about being examined for these kinds of cancer.  
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Burden of Oral and Throat Cancer in Maine
■ Between 1995 and 1996 an average of 99 cases were diagnosed in men and
52 cases in women per year.
■ 26 men and 12 women died from oral and throat cancer per year.  
■ Over 65% of the cases in Maine occur in people over 60 years old. 
The age-adjusted 
incidence rates of oral
and throat cancer in
Maine men and women
were not statistically
different from the U.S.
rates.
Age-Adjusted Incidence Rates by Sex, Maine and U.S.
Oral and Throat Cancer, 1995-1996
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The age-adjusted 
mortality rates for oral
and throat cancer were
not statistically 
different for men and
women in Maine than
in the U.S.
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
Oral and Throat Cancer, 1995-1996
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Oral and throat cancer
is more common as 
people age. The age-
specific rates are much
higher for men than for
women, reflecting
increased use of tobac-
co products, including
chewing tobacco, and
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Cervical Cancer in the U.S.
Both incidence and mortality for invasive cancer of
the cervix have declined steadily in this country over
the past three decades. The U.S. incidence rates are
generally lower than other parts of the world, such
as India and South America. These trends are largely
due to successful use of Pap smears to detect pre-
malignant changes or early cancer. However, in spite
of our ability to prevent this cancer, an estimated
15,700 women in the U.S. were diagnosed with
cervical cancer and 4,900 died from it in 1996.
Additionally, African American women are nearly
twice as likely to get cervical cancer as White
women.
Cervical Cancer
The two most 
important measures 
a woman can take 
to reduce her 
chance of getting 
cervical cancer are to 
get regular Pap smears
and to use safer 
sex practices
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Risk Factors for Cervical Cancer
Most cervical cancers (85%) are associated with human papilloma virus (HPV), a virus passed
along through sexual contact. The following behaviors make HPV infection — and therefore
cancer — of the cervix more likely:
■ A higher number of sexual partners over a lifetime
■ Sexual activity with a man who has had multiple sexual partners
■ Early age at first intercourse
Other factors that may influence the development of cervical cancer are:
■ Long-term oral contraceptive use
■ Poor immune system function
■ Infection with HIV/AIDS
■ Smoking
Prevention of Cervical Cancer
The two most important measures a woman can take to reduce her chance of getting cervical
cancer are:
■ Get regular Pap smears to screen for early cancer or lesions which may become cancerous
(dysplasias)
■ Use safer sex practices, such as condom use and decreasing the number of sexual partners,
to lower exposure to infectious agents.  
Early Detection
Why is early detection important?  
■ Cases detected early (local disease) have about a 92% chance of living for at least five
more years.
■ Cases detected late (disease that has spread to another part of the body) have only a 15%
chance of living for five more years.
How to Improve your Chances of Detecting 
Cervical Cancer Early:
See your health care provider about regular Pap smears. Women with no risk factors
should do the following:
■ Start having annual Pap smears at age 18 (earlier if sexually active)
■ If three in a row are normal it might be possible to have a Pap smear every 2-3 years
Women with the following risk factors should discuss with their providers having Pap
smears more often:
■ A history of an abnormal Pap smear
■ A history of genital warts or any Sexually Transmitted Disease
■ Known HPV or HIV infection
■ Early age at first sexual intercourse
■ History of multiple sexual partners  
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Burden of Cervical Cancer in Maine
■ From 1995 to 1996, 70 women on average were diagnosed with 
cervical cancer each year.
■ Each year 26 women died of cervical cancer on average. 
■ Over 70% of the cases in Maine occur in women under age 60. 
The age-adjusted 
incidence rates of 
cervical cancer in Maine
were significantly 
higher (more cases) in
Maine than the U.S.
Age-Adjusted Incidence Rates by Sex, Maine and U.S.
Cervical Cancer, 1995-1996
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The age-adjusted 
mortality  rate for 
cervical cancer in Maine
was not statistically 
different from the U.S.
rate.
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
Cervical Cancer, 1995-1996
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Cervical cancer is one 
of the few cancers 
diagnosed in younger,
as well as older,
women. The age 
distribution is younger
because the develop-
ment of cervical cancer
is strongly related to a 
sexually transmitted
virus (human papilloma
virus).
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Melanoma in the U.S.
Melanoma incidence increased faster than any
other cancer in the 1970’s and 1980’s. It is now
the 7th most common cancer in the U.S. In 1996
an estimated 38,300 cases of melanoma were
diagnosed in the U.S. and approximately 7,300
Americans died of the disease. Whites get
melanoma ten times as often as African Americans
and five times as often as Hispanics. Melanoma is
the most common cancer in U.S. men aged 35-44
years and the second most common cancer, after
breast cancer, in women from this age group.
Incidence around the world varies a hundred-fold
with the highest rates among Whites in Australia
and the lowest rates in parts of Asia.
Melanoma
The most important 
thing people can do 
to reduce their chances
of getting melanoma is
to avoid sun exposure.
If you have a 
mole that is changing
(for example in size or
color or sensation) 
see your health care
provider.
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Risk Factors for Melanoma
There are several factors that may increase a person’s chance of getting melanoma:
■ Family history of melanoma
■ Large number of moles (nevi)
■ Presence of atypical moles (dysplastic nevi)
■ Intermittent blistering sunburns, especially in childhood and adolescence
■ Skin that burns easily, tans poorly or freckles
Prevention of Melanoma
The most important thing people can do to reduce their chances of getting melanoma 
is to:
■ Avoid being outside in mid-day hours
■ Use sunscreen
■ Wear hats and long sleeves when in the sun  
Early Detection of Melanoma
Why is early detection important?  
■ Cases detected early (local disease) have about a 96% chance of living for at least five
more years.
■ Cases detected late (disease that has spread to another part of the body) have only a
12% chance of living for five more years.
How to Improve your Chances of Detecting
Melanoma Early
Talk to your health care provider about regular skin exams if you have any of 
the following:
■ Many moles on your skin
■ A history of dysplastic nevi (atypical moles)
■ Family members with melanoma or dysplastic nevi
■ A history of melanoma
If you have a mole that is changing (for example in size or color or sensation) see your
health care provider.
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Burden of Melanoma in Maine
■ On average 95 men and 73 women each year were diagnosed with
melanoma between 1995 and 1996.
■ 20 men and 14 women each year died from melanoma on average.  
■ In Maine, 46% of melanoma cases are diagnosed in people under age 60.  
The age-adjusted 
incidence rates for
melanoma were 
statistically lower (less
cases) for both men and
women in Maine 
compared with the U.S.
This may be due to
underreporting of cases
diagnosed outside the
hospital or the fact that
melanoma is less com-
mon in northern U.S.
Age-Adjusted Incidence Rates by Sex, Maine and U.S.
Melanoma, 1995-1996
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The age-adjusted 
mortality rates for
melanoma in Maine
were not statistically
different from the U.S.
for both males and
females.
Age-Adjusted Mortality Rates by Sex, Maine and U.S.
Melanoma, 1995-1996
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Melanomas frequently
occur in young people,
including teenagers.  
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MALES FEMALES MALES & FEMALES
Primary Site Maine 95% CI SEER Maine 95% CI SEER Maine 95% CI SEER
Whites Whites Whites
All Sites 459.8 (448.3-471.6) 452.0 358.7 (349.3-368.4) 350.8 398.8 (391.6-406.2) 391.9
Lung and Bronchus 86.2 (81.2-91.5) 70.3 53.2 (49.6-57.1) 44.1 67.4 (64.5-70.5) 55.3
Breast 1.2 (0.7-2.0) 1.0 108.1 (102.9-113.5) 114.3 58.7 (56.0-61.6) 61.6
Prostate 116.0 (110.3-122.0) 130.0 — — — — — —
Colon and Rectum 52.8 (48.9-56.9) 50.3 38.8 (35.9-41.9) 36.1 45.0 (42.6-47.4) 42.4
Urinary Bladder 36.4 (33.3-39.9) 30.3 9.4 (8.0-11.1) 8.1 21.0 (19.6-22.6) 17.7
Non-Hodgkins 17.2 (15.0-19.6) 20.3 13.5 (11.7-15.6) 12.7 15.0 (13.4-16.5) 16.3
Lymphoma
Corpus Uteri — — — 24.6 (22.1-27.3) 22.0 — — —
Kidney and Renal  15.4 (13.3-17.8) 12.9 7.6 (6.2-9.2) 6.4 11.1 (9.9-12.4) 9.3
Pelvis
Brain and CNS 8.4 (6.8-10.2) 5.3 5.6 (4.3-7.0) 3.7 6.9 (5.9-8.0) 6.3
Melanoma 13.6 (11.7-15.8) 19.0 9.0 (7.5-10.7) 13.2 11.1 (9.8-12.3) 15.7
Oral Cavity and  15.0 (13.0-17.4) 14.1 6.4 (5.2-8.0) 5.9 10.4 (9.2-11.7) 9.7
Pharynx
Leukemia 10.8 (9.1-12.9) 12.9 6.1 (4.4-8.3) 7.9 8.5 (7.4-9.7) 10.4
Pancreas 9.7 (8.1-11.6) 9.5 7.2 (5.9-8.7) 7.3 8.2 (7.2-9.4) 8.3
Ovary — — — 14.9 (13.0-17.0) 15.3 — — —
Stomach 9.5 (8.0-11.4) 8.6 2.9 (2.1-3.8) 3.4 5.8 (5.0-6.7) 5.7
Larynx 8.9 (7.4-10.8) 6.6 2.8 (2.0-3.9) 1.4 5.5 (4.7-6.6) 3.8
Cervix Uteri — — — 8.9 (7.4-10.6) 6.8 — — —
Multiple Myeloma 5.5 (4.3-7.0) 5.0 3.9 (3.0-5.1) 3.1 4.6 (3.8-5.5) 4.0
Thyroid 2.7 (1.9-3.8) 3.0 6.2 (5.0-7.8) 8.0 4.5 (3.7-5.4) 5.5
Esophagus 7.7 (6.3-9.4) 5.8 1.2 (0.8-1.9) 1.6 4.2 (3.5-5.0) 3.5
Hodgkin’s Disease 3.4 (2.5-4.7) 3.2 2.6 (1.7-3.7) 2.5 3.0 (2.3-3.7) 2.8
Testis 4.0 (3.0-5.3) 5.0 — — — — — —
Liver and Intrahepatic  2.8 (1.9-4.0) 4.7 1.1 (0.7-1.9) 1.9 1.9 (1.4-2.5) 3.2
Bile Duct
Note: All rates are age-adjusted to the 1970 U.S. standard population.
*SEER rates for Whites only
Age-Adjusted Incidence Rates by Sex with 95% Confidence Intervals, Maine and U.S.
Selected Sites, 1995-1996
Data Tables
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MALES FEMALES MALES & FEMALES
Primary Site Maine 95% CI US Maine 95% CI US Maine 95% CI US
Whites Whites Whites
All Sites 223.5 (215.6-231.7) 203.05 152.6 (146.7-158.7) 138.7 181.1 (176.4-186.0) 164.8
Lung and Bronchus 78.3 (73.6-83.3) 67.35 42.4 (39.2-45.7) 34.9 57.8 (55.1-60.7) 48.8
Prostate 26.1 (23.5-29.0) 22.45 — — — — — —
Breast 0.1 (0.0-0.6) 0.25 25.1 (22.6-27.8) 24.4 13.8 (12.5-15.3) 13.6
Colon and Rectum 20.5 (18.2-23.2) 20.45 16.2 (14.4-18.3) 13.9 18 (16.5-19.5) 16.7
Pancreas 10.8 (9.1-12.8) 9.45 7.7 (6.4-9.1) 7.0 9 (8.0-10.2 8.1
Ovary — — — 9.3 (7.9-11.0) 7.8 — — —
Non-Hodgkin’s  8.4 (6.9-10.2) 8.85 6.4 (5.3-7.8) 5.9 7.3 (6.4-8.3) 7.2
Lymphoma
Esophagus 6.3 (5.0-7.9) 5.85 1.3 (0.8-1.9) 1.3 3.5 (2.9-4.3) 3.4
Leukemia 6.8 (5.5-8.4) 8.5 3.7 (2.9-4.7) 4.9 5 (4.3-5.9) 6.4
Kidney and Renal  6.6 (5.3-8.2) 5.1 3.0 (2.2-4.1) 2.4 4.5 (3.8-5.4) 3.6
Pelvis
Urinary Bladder 6.9 (5.6-8.5) 5.7 1.7 (1.2-2.5) 1.7 3.8 (3.2-4.6) 3.3
Stomach 4.8 (3.7-6.2) 5.2 2.3 (1.6-3.1) 2.4 3.3 (2.7-4.1) 3.6
Brain and CNS 6.7 (5.4-8.4) 5.3 3.3 (2.4-4.4) 3.7 4.9 (4.1-5.8) 4.4
Cervix Uteri — — — 2.8 (2.1-3.9) 2.4 — — —
Corpus Uteri — — — 2.7 (2.0-3.7) 3.2 — — —
Oral Cavity and  3.8 (2.8-5.1) 3.65 1.2 (0.7-2.0) 1.4 2.4 (1.9-3.1) 2.4
Pharynx
Liver and Intrahepatic  3.8 (2.8-5.0) 4.7 1.3 (0.8-2.0) 2.2 2.4 (1.8-3.0) 3.3
Bile Duct
Multiple Myeloma 3.8 (2.9-5.1) 3.55 2.2 (1.6-3.1) 2.4 2.8 (2.3-3.5) 2.9
Melanoma 2.9 (2.1-4.1) 3.6 1.4 (0.9-2.2) 1.7 2.1 (1.6-2.7) 2.6
Larynx 2.1 (1.4-3.1) 2.1 0.3 (0.1-0.9) 0.5 1.1 (0.7-1.6) 1.2
Hodgkin’s Disease 0.7 (0.3-1.4) 0.55 0.6 (0.2-1.3) 0.4 0.6 (0.4-1.1) 0.5
Testis 0.4 (0.1-0.9) 0.25 — — — — — —
Thyroid 0.4 (0.1-0.9) 0.35 0.3 (0.1-0.8) 0.4 0.3 (0.2-0.6) 0.4
Note:Note: All rates are age-adjusted to the 1970 U.S. standard population.
*US rates for Whites only
Age-Adjusted Mortality Rates by Sex with 95% Confidence Intervals, Maine and U.S.
Selected Sites, 1995-1996
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County All Sites Lung Colorectal Prostate Breast 
(Males) (Females)
Androscoggin 421.0 78.6 54.0 121.8 98.9
(394.9-448.7) (67.5-91.5) (45.2-64.5) (101.6-145.9) (81.9-119.4)
Aroostook 380.5 57.7 53.3 156.2 90.3
(353.7-409.3) (47.5-70.0) (43.7-64.8) (131.9-184.8) (72.5-112.1)
Cumberland 363.4 56.4 40.4 87.2 113.7
(347.8-379.8) (50.3-63.2) (35.5-46.0) (75.7-100.2) (101.9-126.9)
Franklin 342.7 62.6 42.4 80.5 112.3
(299.3-392.1) (44.6-87.0) (28.2-62.9) (51.8-122.9) (79.5-157.2)
Hancock 487.6 81.0 62.8 115.9 126.2
(449.4-528.8) (66.2-98.9) (49.8-78.9) (89.9-149.0) (100.6-157.2)
Kennebec 422.8 68.8 47.2 127.9 113.7
(398.9-448.1) (59.3-79.7) (39.7 - 56.1) (108.7-150.3) (97.2-132.9)
Knox 384.3 63.1 42.6 103.6 103.6
(346.6-426.1) (48.4-81.9) (31.0-58.1) (76.7-139.0) (77.7-137.4)
Lincoln 410.0 73.6 41.0 117.9 104.9
(367.3-457.6) (56.2-95.8) (28.6-58.2) (86.7-159.3) (76.1-143.7)
Oxford 392.2 69.5 45.1 119.2 94
(359.3-428.1) (56.1-85.9) (35.1-57.9) (94.1-150.7) (72.0-122.4)
Penobscot 432.4 77.1 44.2 136.7 101.3
(410.1-455.9) (67.9-87.6) (37.4-52.2) (118.4-157.8) (86.7-118.2)
Piscataquis 343.9 58.9 31.6 113.0 112.2
(294.0-401.9) (39.6-86.4) (18.1-53.5) (73.9-170.1) (72.9-169.8)
Sagadahoc 321.3 56.1 37.9 42.6 110.1
(280.8-367.5) (39.6-78.7) (25.0-56.6) (22.5-77.0) (79.3-151.7)
Somerset 372.9 59.6 52.3 116.2 108.5
(339.6-409.4) (46.6-76.0) (40.3-67.6) (90.0-149.3) (84.6-138.7)
Waldo 395.9 67.7 31.8 80.9 130.9
(354.3-442.2) (51.1-89.3) (21.0-47.3) (55.8-116.2) (99.9-170.8)
Washington 464.0 99.1 53.6 137.0 83.6
(420.9-511.3) (79.8-122.6) (40.4-70.8) (104.6-178.7) (59.7-116.0)
York 390.6 66.0 36.9 126.6 114.1
(371.0-411.3) (58.0-75.1) (31.2-43.6) (110.3-145.1) (99.7-130.4)
Maine 398.8 66.3 45.2 116.0 108.1
(391.6-406.2) (62.2-70.7) (41.9-48.7) (110.3-122.0) (102.9-113.5)
SEER (Whites) 391.0 55.3 42.4 130.0 114.3
(390.0-393.7) (54.6-56.0) (41.8-43.0) (128.4-131.6) (113.0-115.7)
Note: All rates are age-adjusted to the 1970 U.S. standard population.
Age-Adjusted Incidence Rates by County with 95% Confidence Intervals, Maine, and U.S.
Most Common Sites, 1995-1996
Technical Notes
Reportable Cancers and Site Definitions
Not all cancers diagnosed in Maine are reported to the MCR. Cancers that are reported include all
malignant cancers that are in situ or invasive with the exception of basal and squamous cell carcinoma
of the skin. Site definitions are consistent with those used by the National Institute of Health’s
Surveillance, Epidemiology and End Results (SEER) Program for calculating rates. Therefore, this report
excludes all in situ cancers, with the exception of in situ bladder cancer. For a complete listing of site 
and histology codes used for calculating rates, see ICD-O Codes on page 50 -51.
Age-adjusted rates
Why age adjust?
Different communities have different age structures. The age structure of a community determines what
kind of health problems will be more common. A community made up of more families with young 
children will have more bicycle accidents than a community with more individuals who are older.
Likewise, a community with more individuals who are older will have more chronic disease, including
cancer. Age adjustment allows rates of disease to be compared between different communities with dif-
ferent age structures.
How is age-adjustment done?
Age adjustment is done using a statistical procedure called the direct method. The steps for age-
adjustment are:
1. The number of cases and population of new cancer cases are divided into 5-year age grouping (i.e.
0-4, 5-9, 10-14 …80-84, 85+).
2. Incidence rates are calculated for each age group (called age-specific rates) by dividing the number
of cases in an age group by the population in that age group.
3. A standard population is chosen (we used the 1970 United States Standard population). The 
proportion of the standard population is determined for each age group. This is the weight.
4. The age-specific rate is multiplied by the weight of the respective age group, making a weighted
rate.
5. The weighted rates are added together, giving the age-adjusted rate.
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Technical Notes continued on next page
Here’s an example using all cancers reported in Maine that were diagnosed in 1995:
Age Number of New Population Rates per Weights Weighted
Group Cancer Cases in Maine 100,000 (d) rate
(a) (b) ((a/b) x 100,000) (c x d)
0 - 4 yrs. 11 74513 14 0.084 1.2
5 - 9 yrs. 9 86918 10.4 0.098 1.0
10 - 14 yrs. 11 90552 12.1 0.102 1.2
15 - 19 yrs. 15 85510 17.5 0.094 1.6
20 - 24 yrs. 22 80002 27.5 0.081 2.2
25 - 29 yrs. 44 79689 55.2 0.066 3.7
30 - 34 yrs. 87 100104 86.9 0.056 4.9
35 - 39 yrs. 120 109492 109.6 0.055 6.0
40 - 44 yrs. 190 102875 184.7 0.059 10.9
45 - 49 yrs. 279 89702 311 0.060 18.5
50 - 54 yrs. 379 66641 568.7 0.055 31.1
55 - 59 yrs. 499 53207 937.8 0.049 46.0
60 - 64 yrs. 638 50032 1275.2 0.042 54.1
65 - 69 yrs. 942 50711 1857.6 0.034 63.9
70 - 74 yrs. 1001 44140 2267.9 0.027 60.8
75 - 79 yrs. 886 33773 2623.4 0.019 49.5
80 - 84 yrs. 553 22873 2417.7 0.011 27.2
85+ yrs. 396 20648 1917.9 0.007 14.3
Total 6082 1241382 489.9 1.000 398.1
In the above example, the rate before age adjustment (the crude rate) is 489.9 per 100,000 people and
the age adjusted rate is 398.1 per 100,000 people.
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A Few Words about County Rates
The number of new cancers in a county varies from year to year. Cancer rates therefore also vary from
year to year. With a smaller number of cases, there is more variation from year to year. Here is an 
example of random variation in the number of cases: One county might have 4 cases of brain cancer
one year, 9 cases the next year, no cases the next year, 8 the next and 3 the next year. Over the five
years there are an average of 5 cases. In general, when there are less than 30 cases a year it can be diffi-
cult to distinguish between such normal variation in the number of cases and meaningful changes in the
cancer rates. The limited number of years presented in this report (two) and the small population of
Maine counties mean caution must be used when presenting rates of cancer in some counties. To avoid
presenting unstable numbers (with lots of variation), this report presents county-level data for the four
most common cancer sites — lung, breast (female only), prostate and colon-rectum, as well as all 
cancers combined.
U.S. SEER Rates
What is SEER?
The National Cancer Institute funds the Surveillance, Epidemiology and End Results (SEER) cancer 
registries. SEER collects information on cancers from a statistical sample of the United States population
composed of 13 population-based registries. These registries represent approximately 14 percent of the
US population. The sample is designed to be fairly representative of the U.S. population. Because the
non-white population of Maine is less than 2%, the SEER rates for Whites only were used for all 
comparisons in this report. 
Why is caution needed in interpreting comparisons using an all-white population?
Rates of cancer vary by race. These differences are due to cultural differences in personal habits, dietary
practices, and environmental exposures that may change the risk of cancer in a population. In addition,
many ethnic and racial minorities are at a disadvantage relative to access and availability of health care,
preventative services and health education in part due to language differences as well as low income
and education. Thus minorities may experience increased cancer incidence and mortality. In the U.S.,
people of white race have a higher risk of female breast cancer, melanoma and bladder cancer than 
persons of other races. Whites have a lower risk compared to other races for prostate, colorectal and
cervical cancer. Because the non-white population of Maine is relatively small, in the future we will need
to combine a number of years of data to be able to reliably report rates in these groups. 
Changes in Case-Finding Starting in 1995
Beginning in 1995, physicians, non-hospital facilities, and pathology labs were added to the list of
reporting sources for the registry. In that year, the Maine Cancer Registry also began using death 
clearance death certificates as an additional method of case-finding. 
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Age: The person's age at the time of diagnosis (incidence rates) or death (mortality rates).
Age-Adjusted Rates: A rate that has been statistically modified to eliminate the effect of varying age
distributions in different populations.  Age adjustment is a statistical method that is used to allow health
measures (like rates of disease, death, or injuries) to be compared between communities with different
age structures. 
Age-Specific Incidence Rates: The number of new cases diagnosed per 100,000 people, over a given
time period for a specific age group.  In this report, all rates are reported as an average for 1995 and
1996 and age groups are divided into ten-year groupings (i.e. 0-9, 10-19 …80+).
Burden: For this report, burden is the average number of new cases and deaths that occurred during a
given time period.
Confidence Interval: A range around a measurement conveying the amount of precision. In general,
the wider the range, the less precise the number.
Death Clearance: The process in which death certificates with a cause of death related to cancer are
used to identify cases not already reported to the Maine Cancer Registry.  This process also provides vital
status information for cases already in the registry.
Family History: The occurrence of a disease in a close blood relative, such as a parent, sibling, or child,
that may increase one’s risk of being diagnosed with that disease.
Five-Year Relative Survival Rates: The proportion of people, when other causes of death are taken
into account, who are alive five years after diagnosis. 
ICD-9: The Ninth Revision of the International Classification of Diseases, the classification system used
for all mortality data included in this report.  The ICD-9 is published by the World Health Organization.
ICD-O: The International Classification of Diseases for Oncology, the standards reference for classifying
cancers.  The ICD-O is a further classification of the ICD-9 that is specifically for classifying cancer.  All
cancers diagnosed for this report were classified using the second edition. The ICD-O is published by the
World Health Organization.
Incidence Rate: The number of new cases of a disease occurring in a period of time divided by the size
of the population at risk of becoming a case during that period of time.  The result is often multiplied by
a base number, such as 1,000 or 100,000.
Mortality Rate: The number of deaths attributed to a disease during a specific period of time divided
by the size of the population during that period of time. The result is often multiplied by a base number,
such as 1,000 or 100,000.
Prevalence: The proportion of a defined population affected by a disease at a specified point in time.
The numerator of the proportion comprises all those who have the disease at that instant, regardless of
whether it was diagnosed recently or long ago.  Diseases with a long duration tend to have a higher
prevalence than short-term illnesses.
SEER: SEER is the Surveillance, Epidemiology and End Results, of the National Cancer Institute.  SEER
collects information on cancers from a statistical sample of the United States population composed of
13 population-based registries representing 14% of the U.S. population.
Site: The anatomical site (organ or organ system) in which the cancer starts, for example, the lungs,
colon or bone marrow.
Stage: The extent to which a cancer has progressed.
Statistically Significant: The difference between two rates is considered statistically significant if the
difference would have occurred by chance less than five times out of 100.  If a difference is statistically
significant, it is not likely due to random chance.
ICD-O Codes
Site Category ICD-O-2 Site Codes
Oral Cavity and Pharynx C000-C148 Excludes histologies 9590-9989
Lip C000-C009
Tongue C019-C029
Major Salivary Gland C079-C089
Floor of Mouth C040-C049
Gum and Other Mouth C030-C039, C050-C059, and C060-069
Nasopharynx C110-C119
Tonsil C090-C099
Oropharynx C100-C109
Hypopharynx C129, C130-C139, and C141
Pharynx C140 and C142-C148
Digestive System C150-C269, Excludes histologies 9590-9989
C480-C482, and C488
Esophagus C150-C159
Stomach C160-C169
Small Intestine C170-C179
Colon C180-C189
Rectum and Rectosigmoid C199-C209 and C260
Anus and Anocanal C210-C212 and C218
Liver C220
Intrahepatic Bile Duct C221
Gallbladder C239
Other Biliary C240-C249
Pancreas C250-C259
Retroperitoneum C480
Peritoneum C481-C482
Other Digestive Organs C268-C269 and C488
Respiratory System C300-C399 Excludes histologies 9590-9989
Nasal Cavity and Sinuses C300-C301 and C310-C319
Larynx C320-C329
Lung and Bronchus C340-C349
Trachea and Pleura C339 and C381-C399
Bones and Joints C400-C419 Excludes histologies 9590-9989
Soft Tissue (including Heart) C380, C470-C479, Excludes histologies 9590-9989
C490-C499
Melanoma of Skin C440-C449 Includes histologies 8720-8790 only
Breast C500-C509 Excludes histologies 9590-9989
Eye C690-C699 Excludes histologies 9590-9989
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Female Genital System C530-C589 Excludes histologies 9590-9989
Cervix C530-C539
Uterus C540-C559
Ovary C569
Vagina C529
Vulva C510-C519
Other Female Genital Organs C570-C589
Male Genital System C619-C639 Excludes histologies 9590-9989
Prostate C619
Testis C620-C629
Penis C600-C609
Other Male Genital Organs C630-C639
Urinary System C670-C689 Excludes histologies 9590-9989
Bladder C670-C679
Kidney and Renal Pelvis C649-C659
Ureter C669
Other Urinary Organs C680-C689
Brain & Other Nervous System C710-C729 Excludes histologies 9590-9989
Brain C710-C719
Other Nervous System C710-C719 (meningioma), C700-C709, C720-C729
Endocrine System C379, C739, Excludes histologies 9590-9989
C740-749, and C750-C759
Thyroid C739
Other Endocrine C379, C740-C759    
Lymphomas
Hodgkins Disease Includes histologies 9650-9667 only
Non-Hodgkins Lymphoma Includes histologies 9590-9595 and 9670-9715 only
Multiple Myeloma Includes histologies 9731-9732 only
Leukemias Includes histologies 9800-9941 only
Acute Lymphocytic Includes histologies 9821 and 9828 only
Chronic Granulocytic Includes histologies 9863 and 9868 only
Acute Myeloid Includes histologies 9861, 9867, and 9871-9874 only
Chronic Myeloid Includes histologies 9863 and 9868 only
Other Leukemia Includes histologies 9823, 9820, 9822, 9824-9826,
9860, 9862, 9864, 9866, 9891, 9893, 9890, 9892, 9894, 9801, 
9841, 9803, 9842, 9931, 9800, 9802, 9804, 9827, 9830, 9840, 
9850, 9870, 9880, 9900, 9910, and 9930-9941 only
Unknown and Ill-Defined Sites Excludes histologies 9690-9989
Includes histologies 9720-9723, 9740, 9741, 9760-9764, 
9950-9989 only
Includes C760-C768, C809 for histologies 8000-9589 only
Includes C420-C424 for histologies 8000-9589 only
Includes C770-C779 for histologies 8000-9589 only
Site Category ICD-O-2 Site Codes
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Information Resources
Internet Sites
■ American Cancer Society (ACS) http://www.cancer.org
■ International Association of Cancer Registries (IACR) http://www-dep.iarc.fr/
■ National Cancer Registrars Association (NCRA) http://www.ncra-usa.org
■ CDC Cancer Prevention and Control Program http://www.cdc.gov
■ National Library of Medicine http://www.nlm.nih.gov
■ North American Association of http://www.naaccr.org
Central Cancer Registries (NAACCR)
■ National Cancer Institute (NCI) http://www.nci.nih.gov/
■ SEER Program of National Cancer Institute http://www-seer.ims.nci.nih.gov
■ CancerNet http://www.cancernet.com
■ Oncolink (extensive cancer information and http://www.oncolink.upenn.edu
links to other sites)
■ Post Office (zip codes for known addresses) http://www.usps.gov/ncsc/lookups/
lookup_citystzip.html
■ Switchboard (addresses and phone numbers) http://www.switchboard.com
■ The American College of Surgeons http://www.facs.org
■ The Department of Defense Breast Cancer Guide http://www.bcdg.org
■ Breast Cancer Information Service http://bcis.org
■ National Breast Cancer Foundation http://nationalbreastcancer.org
■ American Association for Cancer Research http://www.aacr.org
■ Wiley Interscience Publications Online (Journals) http://www.interscience.wiley.com
■ Oxford University Press (Professional books and journals) http://www.oup.co.uk/
■ International Agency for Research on Cancer (IARC) http://www.iarc.fr
■ National Cancer Policy Board http://www.nas.edu/cancerbd
■ U.S. Department of Health and Human Services http://www.dhhs.gov
■ National Center for Health Statistics (NCHS) http://www.cdc.gov/nchs
■ World Health Organization http://www.who.int
Publications
North American Association of Central Registries (NAACCR) Publications:  
■ Annual Incidence and Mortality monographs
Cancer in North America, Volume One: Incidence 
Cancer in North America, Volume Two: Mortality
■ Standards for Cancer Registries: 
Volume I: Data Exchange Standards and Record Description
Volume II: Data Standards and Data Dictionary
Volume III: Standards for Completeness, Quality Analysis, and Management of Data    
Volume IV: Standard Data Edits
Organizations
■ Centers for Disease Control and Prevention (CDC)
■ National Cancer Registrars Association (NCRA)
■ National Cancer Institute (NCI)
■ American College of Surgeons (ACoS) 
■ American Joint Committee on Cancer (AJCC)
■ American Cancer Society (ACS)
■ North American Association of Central Cancer Registries (NAACCR)
■ Surveillance Epidemiology and End Results (SEER)
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Maine 
Cancer Registry
11 State House Station
Key Bank Plaza, 4th Floor
Augusta, Maine  
04333-0011
Tel: (207) 287-5272
Fax: (207) 287-4631
